European Commission marks Dec. 6 for Novo-Catalent deal decisionnews2024-11-04T10:58:13+00:00November 4th, 2024|Endpoints News|
Viking’s oral weight loss drug shows promising Phase 1 datanews2024-11-04T02:18:03+00:00November 4th, 2024|Endpoints News|
Novo adds to Wegovy’s cardio strength with hospital admissions analysisnews2024-11-03T20:30:25+00:00November 3rd, 2024|Endpoints News|
CinRx touts positive data from two obesity drug candidatesnews2024-11-03T17:00:18+00:00November 3rd, 2024|Endpoints News|
How RFK Jr. might influence the FDA; Pharma’s Q3 highlights; AbbVie’s latest neuro buyout; and morenews2024-11-02T10:00:54+00:00November 2nd, 2024|Endpoints News|
BMS, J&J and AstraZeneca plea with appeals court to overturn drug price negotiationsnews2024-11-01T18:36:49+00:00November 1st, 2024|Endpoints News|
Maven Clinic cuts 10% of workforce weeks after raising $125Mnews2024-11-01T16:45:40+00:00November 1st, 2024|Endpoints News|
Heritage and Apotex to pay $49.1M in price-fixing settlementnews2024-11-01T16:36:10+00:00November 1st, 2024|Endpoints News|
Novo Nordisk claims late-stage MASH victory, continuing GLP-1’s expansionnews2024-11-01T15:28:32+00:00November 1st, 2024|Endpoints News|
FDA removes hold on three CARsgen CAR-T trials; Ono passes on itolizumabnews2024-11-01T14:38:55+00:00November 1st, 2024|Endpoints News|
